To investigate the effect of B cell-specific EPO-R on bone mass during exogenous EPO stimulation (at supraphysiological levels of this hormone), we treated both control and cKD female mice with either EPO or diluent for 2 weeks (180 IU injected 3 times per week), as previously described 10. Here, EPOR is linked to chronic kidney disease.